The Impact of Early Modification of Upfront Androgen Receptor Signaling Inhibitors on Survival Outcomes in Metastatic Hormone‐Sensitive Prostate CancerShintaro Narita, Takafumi Yanagisawa, Shingo Hatakeyama et al.|The Prostate|2025Cited by 1